Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status

Viloxazine has a long history of clinical use in Europe as an antidepressant, and has recently been repurposed into an extended-release form for the treatment of attention-deficit/hyperactivity disorder in the USA. An immediate-release formulation was approved for the treatment of depression in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Findling, Robert L., Candler, Shawn A., Nasser, Azmi F., Schwabe, Stefan, Yu, Chungping, Garcia-Olivares, Jennie, O’Neal, Welton, Newcorn, Jeffrey H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219567/
https://www.ncbi.nlm.nih.gov/pubmed/34003459
http://dx.doi.org/10.1007/s40263-021-00825-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219567/
https://www.ncbi.nlm.nih.gov/pubmed/34003459
http://dx.doi.org/10.1007/s40263-021-00825-w

Ejemplares similares